Multiple Myeloma Cancer from Diagnosis to Treatment


What Is Multiple Myeloma?

Multiple Myeloma is a cancer of plasma cells, a type of white blood cell found in the bone marrow.

Plasma cells normally make antibodies that help fight infection. In multiple myeloma, these cells become abnormal and multiply uncontrollably, producing large amounts of an abnormal protein called monoclonal protein, which can damage bones, kidneys, and the immune system.


1. Early Signs and Symptoms

Bone pain
Frequent bone fractures
Fatigue and weakness
Frequent infections
Weight loss or loss of appetite
Nausea or constipation
Excessive thirst or frequent urination
Swelling in legs


2. Causes and Risk Factors
The exact cause is unknown, but risk factors include

Family history of myeloma or related plasma cell disorders
Exposure to radiation or industrial chemicals
Obesity and chronic inflammation


3. Diagnostic Procedure

Blood Tests
Complete Blood Count:
Detects anemia or low platelets.

Serum Protein Electrophoresis:
Detects abnormal M protein.

Free Light Chain Assay:
Measures excess antibody light chains.

Calcium and Creatinine Levels:
High calcium and kidney dysfunction are common in myeloma.

Urine Tests
Urine Protein Electrophoresis:
Checks for Bence-Jones protein | a form of M protein.

Imaging Tests
X-rays, MRI, CT scan, or PET scan show bone damage or lesions.

Bone Marrow Aspiration and Biopsy
Confirms diagnosis by detecting abnormal plasma cells.


4. Types and Staging

The Revised International Staging System uses:
Levels of β2-microglobulin and albumin in the blood
Presence of chromosomal abnormalities
Lactate Dehydrogenase level

Stage I - Low tumor burden, normal LDH, favorable genetics.
Stage II - Intermediate features.
Stage III - High tumor burden, abnormal LDH, or high-risk genetics.


5. Treatment Options

Targeted Therapy

Bortezomib, Carfilzomib, Ixazomib ➧ block proteasomes to kill cancer cells.
Venetoclax ➧ targets specific genetic subtypes.

Immunomodulatory Drugs

Lenalidomide, Thalidomide, Pomalidomide ➧ boost immune attack on cancer cells.

Monoclonal Antibody Therapy

Daratumumab, Isatuximab, Elotuzumab ➧ help the immune system recognize and destroy myeloma cells.

Chemotherapy

Melphalan, Cyclophosphamide ➧ used in combination with steroids or other agents.

Corticosteroids

Dexamethasone or Prednisone ➧ reduce inflammation and kill myeloma cells.

Stem Cell Transplant

Patient’s own stem cells are collected, high-dose chemotherapy is given to destroy diseased marrow, and stem cells are reinfused.

Radiation Therapy

Used for localized bone lesions causing pain or fractures.


6. Preferred Nutrition for Patients

Protein-rich foods:
ggs, fish, chicken, beans, lentils.

Calcium-rich foods:
milk, yogurt, cheese | if kidneys are healthy.

Fruits & vegetables:
spinach, kale, berries, oranges.

Whole grains:
oats, brown rice.

Hydration:
at least 2-3 liters of water daily | unless restricted by doctor.

Healthy fats:
olive oil, nuts, avocado.


7. Follow-Up

Regular blood tests, bone scans, and kidney monitoring are essential.

Some patients may experience remission and relapse cycles.